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have been reported, acute pancreatitis has never been reported.To our knowledge, this is the first 
of probable primary Cephalexin-induced acute pancreatitis. A 55 years old female patient with 
past medical history significant for multiple sclerosis (MS), basal cell carcinoma (BCC), history 
laparoscopic cholecystectomy due to gallstones had excision of BCC done in dermatology clinic 
and received a dose of 500 mg Cephalexin for prophylaxis. Three hours later, she presented to emer-
gency department (ED) for sudden onset of upper abdominal pain radiating to back. The pain was 
associated with severe nausea and poor appetite. She denied history of drinking alcohol, trauma, 
insect or scorpion bite and previous history of pancreatitis. Her medication list included Fingoli-
mod (Gilenya) and Oxcabazepine both of which she was taking for years without any side effects. 
Abdominal examination revealed epigastric tenderness, with no rebound or palpable masses. Initial 
laboratory workup revealed lipase of 889 Units/L (6 times upper normal limit). However, CT abdo-
men in the ED was negative for peripancreatic fat stranding, fluid collection, and pancreatic focal 
lesions. Based on abdominal pain and elevated lipase three-time upper normal limit, the patient was 
diagnosed with acute pancreatitis. She was admitted and started on aggressive intravenous hydra-
tion. Further work up showed normal liver enzymes and serum triglyceride of 68 mg/dl. IgG sub-
classes were normal. Ultrasound showed unremarkable liver, absent gallbladder, and extra hepatic 
duct measured 10 mm. MRCP was obtained, which showed mild extrahepatic duct dilatation up to 
[1332C] Cholangioscopy image.
11 mm without any dominant stricture or stone. Cephalexin was discontinued. Four days later her 
appetite improved and pain resolved and she was discharged home on low fat diet. In the absence 
of other causes of acute pancreatitis, cephalosporins such as Cephalexin should be considered as 
a potential etiologic factor of acute pancreatitis in patients who present with abdominal pain and 
elevated serum lipase levels.
1334
Portal Cavernoma Cholangiopathy Secondary to Polycythemia Vera: Case Report and 
Echoendoscopic Findings
Vítor Magno Pereira, MD1, Pedro Costa-Moreira, MD2, Pedro Moutinho-Ribeiro, MD, MSc2, Guilherme 
Macedo, MD, PhD, FACG3. 1Centro Hospitalar do Funchal, Funchal, Madeira, Portugal; 2Department of 
Gastroenterology - Centro Hospitalar de São João, Porto, Portugal, Porto, Portugal; 3Centro Hospitalar de 
São João, Porto, Portugal
Portal cholangiopathy describes the abnormalities arising anywhere in the wall of biliary tree as a 
result of extrahepatic portal hypertension. This includes extra and intrahepatic bile duct narrowing 
and dilatation, and choledochal varices both favoring cholestasis and stone formation. The pathogen-
[1333] Characteristics findings of published case reports of Cephalosporin induced pancreatitis.
[1334A] EUS image showing dilatation of CBD (13mm) at the level of the hepatic 
hilum and the portal vein.
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esis implies a reversible component, the compression of collaterals, and a fixed component, conse-
quence of ischemia at the time of portal vein thrombosis. This can be associated with hematological 
and coagulation disorders such as myelodysplastic syndromes or protein C deficiency. Endoscopic 
ultrasound (EUS) is considered the modality of choice for evaluating common bile duct obstruction, 
however its role in evaluating collateral vascular pathways in and around the common bile duct is 
poorly defined. We present a case of a 67-year-old woman with polycythemia vera diagnosed 19 years 
before, that culminated in thrombosis of portal, superior mesenteric and splenic veins. She had a 
previous history of cholecystectomy for gallstones. During the last decade, she developed various epi-
sodes of esophageal variceal hemorrhage. A right quadrant biliary-type pain associated with persistent 
elevation of alkaline phosphatase was also reported. She underwent Magnetic Resonance Cholangio-
pancreatography (MRCP) that showed exuberant cavernomatous portal vein transformation by previ-
ous portal thrombosis and significant stenosis at the confluence of the right and left hepatic ducts, 
with upstream ectasia. Due to edema and unspecific alterations at the hepatic hilum, it was not pos-
sible to exclude suspicious lesions. EUS was then performed, which showed a serpiginous trajectory 
of the common bile duct (CBD) from the hepatic hilum to its supra-pancreatic portion. Large para 
and peri-choledochal varices were observed, as well as intrapancreatic venous collaterals. This exten-
sive network of neo vessels was responsible for the compression of the biliary tree and its upstream 
dilatation. EUS excluded other etiologies for CBD dilatation. This case illustrates EUS potential in 
the algorithm of management of portal colangiopathy, particular in symptomatic cases. Its imaging 
resolution (associated with Doppler) can trace the origin, caliber, entry and course of varices outside 
and throughout the CBD. The careful study of collateral vessels prior to therapeutic interventions 
(as ERCP) can help to plan the procedure and manage anticipated complications such as hemobilia.
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A 58 year old female presented to our group for work up of abdominal pain and pancreatic mass revealed 
on a previously obtained abdominal CT scan. She had past medical history significant for type 2 diabe-
tes, arthritis, and hypertension. She had no history of abdominal surgeries, and specifically denied his-
tory of alcohol use. Physical exam revealed a soft abdomen and no hepatosplenomegaly. Her laboratory 
studies including a CA 19-9 were unremarkable. EGD with endoscopic ultrasound (EUS) was performed 
and a 16 mm x 17 mm round, well-defined, hypoechoic exophytic lesion in the posterior pancreatic head 
(not involving the PD) was noted. This lesion was abutting the major veins at the portal confluence, how-
ever there was no evidence of invasion into the vessels. Elastographic EUS showed a predominantly solid 
mass. Based on the EUS, the differential diagnosis included neuroendocrine tumor and rare lymphoepi-
thelial keratinized cystic lesion. Pathology from FNA biopsy reported scant pancreatic tissue insufficient 
for a definitive diagnosis. Ultrasonography of the abdomen showed a solid hypodense heterogeneous 
mass. A CT with contrast confirmed the presence of a 2.0 x 2.2 x 1.7 cm rounded space occupying mass 
lesion in the pancreatic head. Finally an MRI with contrast showed that the mass was medial to the 
portal confluence abutting the posterior aspect of the pancreatic head. The findings were suggestive of a 
splenic artery pseudoaneurysm that might be clotted off. Discussion:- Splenic artery pseudoaneurysm 
(SAP) is an uncommon finding, with only 157 cases being reported in English-language literature. 77.3% 
of cases were found in males. Mayo clinic reported 10 cases over 18 years (1980 to 1998). The most 
common causes of SAP include chronic pancreatitis (46%), abdominal trauma (29%), iatrogenic and 
postoperative complications (3%), and peptic ulcer disease (2%). Following pancreatitis, SAP can be 
caused by the leakage of pancreatic enzymes, which eventually leads to necrotizing arteritis and subse-
quent vessel wall destruction. Pancreatic pseudocyts can occur in conjunction with SAP 41% of cases. 
The most common symptoms associated with SAP are hematochezia or melena at 26%, hematemesis at 
16%, abdominal pain at 29% as well as hemosuccus pancreaticus at 20%. Diagnosis is most commonly 
made with angiography (52%) followed by CT scan (36%). Since the risk of rupture is high (37%), urgent 
repair of SAP’s is paramount regardless of the size of the SAP.
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Systemic Lupus Erythematosus (SLE) is a common rheumatologic condition with known GI involve-
ment, most notably autoimmune hepatitis and lupus colitis. Acute pancreatitis (AP) is a rare complica-
tion of SLE and is typically associated with disease activity. Macrophage activation syndrome (MAS) 
is an unusual, hyper-inflammatory response to a rheumatologic stimulus characterized by hyperfer-
ritinemia, pancytopenia, thermal dysregulation and multiorgan dysfunction. MAS, more commonly 
seen in children, has been reported to complicate both adult onset SLE and AP. We present a case of 
necrotizing AP secondary to an SLE flare ultimately complicated by MAS in an adult patient and suc-
cessfully treated with Anakinra. A 29 year-old female with SLE and non-adherence to medical therapy 
was admitted with severe necrotizing AP evidenced by epigastric pain, nausea, oral intolerance, lipase 
>3000 U/L, and CT scan demonstrating necrosis and inflammation in the pancreatic head. After 
admission, she developed tachycardia, hypothermia, lactate elevation of 17.2, and hypercarbic respira-
tory failure with pulmonary edema requiring intubation and mechanical ventilation with aggressive 
supportive care. Laboratory evaluation demonstrated evidence of DIC with pancytopenia, elevated 
ANA/ds DNA, and a ferritin of 1332 ng/mL. She was started on methylprednisolone for treatment of 
a SLE flare with clinical improvement leading to extubation. Following extubation, her ferritin level 
doubled in association with clinical deterioration raising suspicion for MAS. She was then started on 
Anakinra resulting in brisk clinical response and down trending ferritin. AP occurs in 1-8% of SLE 
patients and is proposed to be the result of vascular damage. MAS complicates approximately 5.5% of 
childhood SLE compared to 0.7% of adult SLE but is more commonly the result of AP in combination 
with SLE compared to SLE alone and is associated with higher mortality rates. Our case uniquely 
illustrates a rare etiology of AP and the relationship between systemic diseases and the GI system in a 
critically ill patient. Treatment of MAS is aimed at treating the underlying SLE; however, our patient 
required the addition of a chemotherapeutic agent. Anakinra is a novel agent which has been used to 
treat refractory childhood MAS and was successful in treating this adult patient. To the best of our 
knowledge, this is the only reported case of refractory MAS due to SLE induced AP necessitating 
treatment with Anakinra.
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Gallbladder adenocarcinoma (GBAC) is an uncommon but highly fatal malignancy. It follows an 
aggressive course and complete remission is rare. Germline BRCA1 mutations have been linked 
with an increased risk of several abdominal malignancies, most prominently pancreatic cancer 
and more recently hepatobiliary malignancies. A 47-year-old female with history of gastroesopha-
geal reflux disease presented to the clinic with a 2-month history of abdominal discomfort. Family 
history was unknown as she had no contact with her family. Exam was notable for scleral icterus 
and right upper quadrant abdominal tenderness. Labs were notable for conjugated hyperbilirubine-
mia. Computed tomography of the abdomen revealed a 6x5-centimeter hypodense left hepatic lobe 
mass and regional lymphadenopathy (figure 1). CA 19-9 was elevated at 214 U/mL. Endoscopic retro-
grade cholangiopancreatography with papillotomy was performed and aspiration biopsy of the peri-
pancreatic lymph nodes revealed adenocarcinoma. She then underwent exploratory laparotomy with 
Whipple’s procedure and biopsy of the hepatic lesion revealed GBAC (figure 2). Adjuvant chemotherapy 
with gemcitabine and cisplatin was not tolerated due to side effects. Three years later, she was diagnosed 
with right-sided breast cancer for which she underwent surgical resection. Given the personal history 
of two malignancies diagnosed under the age of 50 and the limited family history, genetic testing was 
pursued and patient tested positive for BRCA1 mutation (c.5177_5180delGAAA (p.Arg1726LysfsX3)). 
She later underwent prophylactic hysterectomy and bilateral salpingo-oophorectomy. Association of 
hepatobiliary tumors with BRCA1 mutations has been described in several population studies. How-
ever, GBAC in the setting of BRCA1 mutation has been previously described in only one case report. 
Unique to our patient with germline BRCA1 mutation is the diagnosis of GBAC as the patient's first 
malignancy. Therefore, germline BRCA1 mutations need to be considered in patients with GBAC and 
atypical features such young age and absence of risk factors. Referral to a geneticist is appropriate in such 
cases as this can reduce future risk of other malignancies by genetic counseling, enhanced screening and 
prophylactic surgeries.
[1334C] EUS image showing the distal portion of CBD with a normal diameter (4mm) 
and intrapancreatic venous collaterals.
[1334B] EUS image at the level of hepatic hilum showing portal vein thrombosis with 
para and peri-choledochal varices.
